NCT04069299View on ClinicalTrials.gov

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

June 6, 2025

Study Completion Date

January 31, 2026

Conditions
Neuroendocrine Carcinoma
Interventions
DRUG

68Ga-DOTATATE

The NETspot kit is 2 vials, Vial 1 contains 40 mcg dotatate, 5 mcg 1,10phenanthroline; 6mcg gentisic acid and 20 mg mannitol. Vial 2 contains 60 mg formic acid, 56.5 mg sodium hydroxide and water for injection

DIAGNOSTIC_TEST

Positron Emission Tomography (PET) Scan

PET scan is an imaging test using radioactive tracers.

Trial Locations (1)

33612

H Lee Moffitt Cancer & Research Institute, Tampa

Sponsors
All Listed Sponsors
collaborator

Advanced Accelerator Applications

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER